Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma. Studies with cell lines and animal studies.

Source:http://linkedlifedata.com/resource/pubmed/id/20126826

Download in:

View as

General Info

PMID
20126826